FDA
-
-
-
-
-
-
-
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
-
-
-
-
-
-
-
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
-
-
-
-
-
-
-
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio (CLYM) Appoints Perrin Wilson as Chief Business Officer
-
-
-
-
-
-
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
-
323,584 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

